Data from trials wowed ESMO in September 2020, where Trodelvy was shown to significantly extend overall survival (OS) and improved overall response rate (ORR) and clinical benefit rate (CBR ...

This year, Trump managed to win back a few states that he lost in 2020 but won in 2016, when he punctured the Democratic "blue wall" and claimed the presidency. Projected victories in North ...

“ESMO 2022 had really outstanding sessions for ... as well as fallopian tube and primary peritoneal cancer. In 2020, there were over 55,000 new diagnoses of ovarian cancer in China.

Once the votes were counted in the 2020 presidential election, the result was clear: The pollsters had lost once again.

Exit polls are surveys of voters taken as they exit their polling place. The exit poll also includes interviews with early in-person voters and a telephone poll is conducted for absentee voters.

Shares of Sutro Biopharma (NASDAQ:STRO) fell by 17% in September after the company's ESMO (European Society for Medical Oncology) update. 3-year performance isn't looking much better at -81% ...

Nat Geo’s 21 most compelling images of the 21st century Nat Geo’s 21 most compelling images of the 21st century These are our best animal photos of 2020 These are our best animal photos of ...

Please verify your email address. Your browser does not support the video tag. Even though the 2020s have just begun, the decade has already produced several ...

Here's how many cast their ballot in 2020. According to the U.S. Census Bureau, the 2020 presidential election saw the highest voter turnout of the 21st century with "66.8% of citizens 18 years ...

Tracking the state of the race between President Donald Trump and his Democratic rival Joe Biden, updated as polls are released. The NBC News National Polling Average is based on an unweighted ...

Follow the latest on Election 2020 Of President Trump’s voters, about 6 in 10 said the economy was their most important issue. Roughly a third of former vice president Joe Biden’s voters said ...

September 16, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in MRD testing, announced findings presented this week at the European Society of Medical Oncology Congress (ESMO) Congress 2024 in ...